Delivery Order SPE2DB22D2005-SPE2DB25FJTC2
- Not listed
- The Defense Logistics Agency awarded a $13,303.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One syringes (6mL) on September 15, 2025, with an ultimate completion date of September 16, 2025. The award, which carries no set-aside designation, represents a competitive procurement fulfilled by the pharmaceutical distributor from its Conshohocken, Pennsylvania corporate office. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,939.45 to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $19,398.41 on July 29, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract requires no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,479.42 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a joint care injection medication. This firm fixed-price contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Synvisc-One syringes (6mL) with a ceiling value of $3,885.12 under a firm fixed-price contract type. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 22, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,605.68 to AmerisourceBergen Drug Corp for SYNVISC-One Syringe 6ml, a hyaluronic acid-based joint injection used to treat osteoarthritis symptoms. The contract, issued on September 9, 2025, with a completion date of September 10, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,942.56 to AmerisourceBergen Drug Corp for SYNVISC-One Syringes (6mL) on June 5, 2025, with completion scheduled for June 6, 2025. This non-set-aside, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This is a firm fixed price delivery order with a ceiling value of $6,009.24 and an ultimate completion date of July 2, 2025. The contract represents a non-competitive award utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,942.56 delivery order on July 29, 2025, for Synvisc-One Syringe 6ML, a hyaluronic acid-based intra-articular injection used for osteoarthritis pain management. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition...
- The U.S. Defense Department's Medical Supply Chain awarded a $21,774.84 delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 1, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJTC2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,638.88 to AmerisourceBergen Drug Corp for the supply of Synvisc Syringes (2ML) on September 17, 2025, with completion expected by September 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company's federal contract awards reflect its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains through open competition. This Synvisc Syringe delivery order supports the Defense Logistics Agency's medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the comprehensive prime vendor contract structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 9/17/25 |